InsidersTradesSigma
Follow the 오션스바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 오션스바이오 has recorded 1 insider filings. The latest transaction was reported on 4 April 2025 (Sale). Among the most active insiders: 강귀염. Every trade is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 April 2025
关于 오션스바이오
오션스바이오 在医疗保健和制药领域运营，并在XKRX上市。该公司专注于开发创新的生物解决方案。